{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:22:49Z","timestamp":1755696169785,"version":"3.40.5"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,7]]},"abstract":"<jats:p>Since liver tests are not routinely checked in pregnancy, the prevalence of abnormal liver tests and liver-related abnormalities in pregnancy in a US-based population is not known. We sought to determine the prevalence of abnormal alanine aminotransferase (ALT) among pregnant Individuals who present to labor and delivery for evaluation and to evaluate prevalence of underlying diagnosed liver conditions. Prospective study evaluating liver tests in consecutive samples obtained on the labor and delivery unit. Patient characteristics were compared between those with and without abnormal ALT and those with and without abnormal ALT without a liver-related diagnosis made in clinical practice, using <jats:italic toggle=\"yes\">t<\/jats:italic> tests for continuous measures and \u03c72 or Fisher\u2019s exact tests as appropriate for categorical measures. Logistic regression was utilized to identify factors associated with abnormal ALT in this subcohort to determine predictors of abnormal ALT in those without a known liver-related diagnosis. We collected 1024 laboratory specimens from 996 patients. Of these patients, 131 of 996 (13.2%) had elevated ALT \u226525 IU\/L; 20 (2%) had ALT \u226550, 6 (0.6%) had ALT \u2265125 and 3 (0.3%) had ALT \u2265250. 61\/131 (46.6%) of patients with ALT \u226525 IU\/L had not had LTs checked during routine pregnancy care. 20 (15%) of individuals with abnormal LT had preeclampsia; 5 (4%) had cholestasis of pregnancy; 1 (0.8%) had hepatitis C; there were no other chronic liver diseases diagnosed. There were no significant demographic or clinical differences between those with and without ALT \u226525, whether liver disease diagnosis was made or not. We identified an over 10% prevalence of abnormal LTs in consecutive pregnant individuals who presented to L&amp;D, most of whom did not have a liver-related condition diagnosed in clinical practice. Among those with liver-related diagnoses, PE and ICP were the most common among individuals with ALT\u226525 IU\/mL, with chronic liver disease rarely diagnosed. Further evaluation of the role of ALT testing as part of routine prenatal care is needed, particularly in establishing a baseline prevalence of liver test abnormalities in pregnancy and independent association with pregnancy outcomes.<\/jats:p>","DOI":"10.1097\/md.0000000000030408","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T15:24:47Z","timestamp":1665415487000},"page":"e30408","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence of elevated alanine aminotransferase (ALT) in pregnancy: A cross-sectional labor and delivery-based assessment"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6663-6253","authenticated-orcid":false,"given":"Tatyana","family":"Kushner","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Science and the Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Masand","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Science and the Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Rosenbluth","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carin","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Grace","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Rodriguez-Rivas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hernis","family":"De La Cruz","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Center for Biostatistics, Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Overbey","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Center for Biostatistics, Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhoda","family":"Sperling","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Science and the Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ajg.2015.430","article-title":"ACG clinical guideline: liver disease and pregnancy.","volume":"111","author":"Tran","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.51.6.876","article-title":"Prospective study of liver dysfunction in pregnancy in Southwest Wales.","volume":"51","author":"Ch\u2019ng","year":"2002","journal-title":"Gut"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.aohep.2019.04.009","article-title":"Liver disease in pregnancy: medical aspects and their implications for mother and child.","volume":"18","author":"Garcia-Romero","year":"2019","journal-title":"Ann Hepatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"524e1","DOI":"10.1016\/j.ajog.2014.10.1093","article-title":"Recent trends in hepatic diseases during pregnancy in the United States, 2002-2010.","volume":"212","author":"Ellington","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/ajg.2016.462","article-title":"Corrigendum: ACG clinical guideline: liver disease and pregnancy.","volume":"111","author":"Tran","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.12659\/MSM.907723","article-title":"Liver disease during pregnancy: a challenging clinical issue.","volume":"24","author":"Mikolasevic","year":"2018","journal-title":"Med Sci Monit"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/hep.22130","article-title":"Liver disease in pregnancy.","volume":"47","author":"Hay","year":"2008","journal-title":"Hepatology"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries.","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.31559","article-title":"Reproductive health and liver disease: practice guidance by the American Association for the Study of Liver Diseases.","volume":"73","author":"Sarkar","year":"2021","journal-title":"Hepatology"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"ofaa514","DOI":"10.1093\/ofid\/ofaa514","article-title":"Hepatitis C seroprevalence among consecutive labor and delivery admissions in two New York City Hospitals.","volume":"7","author":"Kushner","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-2008-1078756","article-title":"Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy.","volume":"25","author":"Lee","year":"2008","journal-title":"Am J Perinatol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2020.03.049","article-title":"Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes.","volume":"73","author":"Sarkar","year":"2020","journal-title":"J Hepatol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ebiom.2017.11.014","article-title":"Liver Dysfunction during pregnancy and its association of with preterm birth in China: a prospective cohort study.","volume":"26","author":"Zhuang","year":"2017","journal-title":"EBioMedicine"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"e000913","DOI":"10.1136\/bmjgast-2022-000913","article-title":"Fatty liver index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy.","volume":"9","author":"Koralegedara","year":"2022","journal-title":"BMJ Open Gastroenterol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.14309\/ajg.0000000000000101","article-title":"Noninvasive tests for prognosticating outcomes in patients with chronic liver disease in pregnancy: ready for prime time?","volume":"114","author":"Kushner","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/00365521.2019.1629007","article-title":"Transient liver elastography in normal pregnancy - a longitudinal cohort study.","volume":"54","author":"Stenberg Ribeiro","year":"2019","journal-title":"Scand J Gastroenterol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:41:06Z","timestamp":1746333666000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":16,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030408","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}